{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:24:56Z","timestamp":1787793896891,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Melasma is an acquired hyperpigmented skin disorder. Tranexamic acid (TXA) prevents ultraviolet radiation induced pigmentation in melasma through interfering with the plasminogen\u2013plasmin pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>This study was conducted to evaluate the therapeutic effect and safety of TXA by intradermal injection versus TXA with microneedling for melasma treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Fifty-six female patients with bilateral symmetrical melasma were recruited in a split-face study. All patients received an intradermal injection of TXA on one side of the face, and the other side received TXA with microneedling for 6 sessions at 2 weeks intervals. Clinical efficacy was assessed using a modified Melasma Area Severity Index (mMASI) score at the baseline and after treatment. Global photographs underwent blinded review by 2 dermatologists. Patient self-assessment and satisfaction were recorded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>After the treatment, the mMASI score was significantly reduced compared with the baseline in both treated sides (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001). No significant difference between both treated sides (<jats:italic toggle=\"yes\">p<\/jats:italic> &gt; .05). Patient satisfaction was higher in the microneedling-treated side than the intradermal-injected side (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001). No significant adverse effects were observed in both treated sides.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Intradermal injection and microneedling of TXA could be safe and effective in melasma treatment. Microneedling of TXA was significantly more satisfying to the patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002449","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T06:01:06Z","timestamp":1595484066000},"page":"e102-e107","source":"Crossref","is-referenced-by-count":34,"title":["Tranexamic Acid for Melasma Treatment: A Split-Face Study"],"prefix":"10.1097","volume":"46","author":[{"given":"Howyda M.","family":"Ebrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Said Abdelshafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathia","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Gharib","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Dermatology, Venereology, and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4103\/0378-6323.98071","article-title":"Newer and upcoming therapies for melasma","volume":"78","author":"Sarkar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/0378-6323.79741","article-title":"Pattern and prevalence of physiological cutaneous changes in pregnancy: a study of 2000 antenatal women","volume":"77","author":"Rathore","year":"2011","journal-title":"Ind J Dermatol Venerol Leprol"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/2349-5847.147044","article-title":"Recent advances in melasma","volume":"1","author":"Chatterjee","year":"2014","journal-title":"Pigment Int"},{"key":"R4-20230814","first-page":"388","article-title":"Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial","volume":"28","author":"Sun","year":"2014","journal-title":"JEADV"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0974-2077.118403","article-title":"A randomized, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma","volume":"6","author":"Budamakuntla","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"key":"R6-20230814","first-page":"228","article-title":"Tranexamic acid in melasma: a review. Pigmentary disorders","volume":"2","author":"Poojary","year":"2015","journal-title":"J Pig Dis"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jocd.12026","article-title":"Tranexamic acid: an important adjuvant in the treatment of melasma","volume":"12","author":"Tse","year":"2013","journal-title":"J Cosmet Dermatol"},{"key":"R8-20230814","first-page":"2","article-title":"Skin cell proliferation stimulated by microneedles","volume":"4","author":"Liebl","year":"2012","journal-title":"J Am Coll Clin Wound Spec"},{"key":"R9-20230814","first-page":"354","article-title":"Automated microneedling device\u2013A new tool in dermatologist's kit\u2013A review","volume":"22","author":"Arora","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","article-title":"Microneedles: an emerging transdermal drug delivery system","volume":"64","author":"Bariya","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/DSS.0000000000000974","article-title":"Reliability, validity, and sensitivity to change over time of the modified Melasma Area and Severity Index score","volume":"43","author":"Abou-Taleb","year":"2017","journal-title":"Dermatol Surg"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","article-title":"Hyper-pigmentation and melasma","volume":"6","author":"Rigopoulos","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3126\/kumj.v10i4.10993","article-title":"Oral tranexamic acid for the treatment of melasma","volume":"10","author":"Karn","year":"2012","journal-title":"Kathmandu Univ Med J"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00042728-200605000-00004","article-title":"Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial","volume":"32","author":"Lee","year":"2006","journal-title":"Dermatol Surg"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jocd.12152","article-title":"Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma","volume":"14","author":"Banihashemi","year":"2015","journal-title":"J Cosmet Dermatol"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/ced.12835","article-title":"Efficacy and possible mechanisms of topical tranexamic acid in melasma","volume":"41","author":"Kim","year":"2016","journal-title":"J Clin Exp Dermatol"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/ced.13164","article-title":"Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study","volume":"42","author":"Sharma","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"R19-20230814","first-page":"30250","article-title":"Microneedling: where do we stand now? A systematic review of the literature","volume":"17","author":"RAmaut","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R20-20230814","first-page":"158241","article-title":"Skin needling to enhance depigmenting serum penetration in the treatment of melasma","volume":"2011","author":"Fabbrocini","year":"2011","journal-title":"Plast Surg Int"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/DSS.0000000000001248","article-title":"Microneedling: a review and practical guide","volume":"44","author":"Alster","year":"2018","journal-title":"Dermatol Surg"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/PRS.0b013e318188245e","article-title":"Percutaneous collagen induction: minimally invasive skin rejuvenation without risk of hyperpigmentation-fact or fiction?","volume":"122","author":"Aust","year":"2008","journal-title":"Plast Reconst Surg"},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaad.2015.09.024","article-title":"Microneedling in skin of color: a review of uses and efficacy","volume":"74","author":"Cohen","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:19:30Z","timestamp":1692044370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002449","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}